COMMUNIQUÉS West-GlobeNewswire

Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global

27/06/2024 - 14:30

Kane Also Signs Long-Term Manufacturing Agreement With Halo Pharma WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made [...]

Comedian and Actor Drew “Druski” Desbordes Joins Safety Shot as Their Newest Brand Ambassador

27/06/2024 - 14:30

Druski Joins the Company’s Impressive Portfolio of Creators and Celebrities to Boost Awareness of the Revolutionary Beverage with a Wide Range of Consumers JUPITER, FL, June 27, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc [...]

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

26/06/2024 - 22:57

Ohtuvayre is indicated for the maintenance treatment of COPD allowing for broad use in COPD patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects Conference call [...]

Oragenics, Inc. Announces Closing of Public Offering

26/06/2024 - 22:47

SARASOTA, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced [...]

Tonix Pharmaceuticals Announces Proposed Public Offering

26/06/2024 - 22:40

CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced that it intends to offer and [...]

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement

26/06/2024 - 22:15

FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]

Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs

26/06/2024 - 22:05

SAN FRANCISCO, June 26, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment [...]

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

26/06/2024 - 22:01

MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as [...]

Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

26/06/2024 - 21:13

CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company, today announced that it has regained compliance [...]

Progyny, Inc. to Host 2024 Inaugural Investor Day

26/06/2024 - 19:42

NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day [...]

Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities

26/06/2024 - 18:46

This new registration statement does not relate to any previously undisclosed new issuances of dilutive securities. Includes issuance of shares underlying warrants originally issued in 2021, earnout shares previously [...]

SMISS Asia Pacific 2024 Congress and training program

26/06/2024 - 18:00

Press release Ecully, June 26, 2024 – 6 p.m. Hands-on surgical training in Hong Kong at the SMISS Asia Pacific 2024 Congress The Spineway Group, a specialist in innovative implants for the treatment of severe spine [...]

Congrès Asie Pacifique SMISS 2024 et programme de formation

26/06/2024 - 18:00

Communiqué de presse Ecully, le 26 juin 2024 – 18h Formations pratiques chirurgicales à Hong Kong lors du congrès SMISS Asia Pacific 2024 Le groupe Spineway spécialiste des implants innovants pour le traitement des [...]

Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board

26/06/2024 - 17:45

Saint-Herblain (France), June 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the [...]

Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale et la nomination d’un nouvel administrateur à son conseil d’administration

26/06/2024 - 17:45

Saint-Herblain (France), le 26 juin 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par son conseil d’ [...]

EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1

26/06/2024 - 17:40

Press Release Agreement with Sanofi on a 200 M€ investment through a Perpetual Subordinated Hybrid Bond, upon the completion of the ongoing discussions to amend and extend the current Revolving Credit Facility 75 to 80 [...]

EUROAPI poursuit sa transformation grâce au plan FOCUS-27 et pose les bases d’une future croissance rentable1

26/06/2024 - 17:40

Communiqué de presse Accord avec Sanofi pour un investissement de 200 millions d’euros via une obligation Hybride Subordonnée à Durée Indéterminée, à l'issue des discussions en cours destinées à amender et à étendre le [...]

Allergy Named Highest-Impact Journal in Allergy and Clinical Immunology for 2024

26/06/2024 - 17:34

ZURICH, Switzerland, June 26, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) is thrilled to announce that Allergy , one of EAACI’s official journals, has been recognised as the [...]

CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change

26/06/2024 - 16:52

HOUSTON, June 26, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is thrilled to introduce the groundbreaking strategies formulated by its freshly appointed Treasurer and Director, Mr [...]